» Articles » PMID: 38552655

Comprehensive Transition of Care for Polycystic Ovary Syndrome from Adolescence to Adulthood

Overview
Specialty Pediatrics
Date 2024 Mar 29
PMID 38552655
Authors
Affiliations
Soon will be listed here.
Abstract

Polycystic ovary syndrome (PCOS) is a lifelong chronic condition that affects one in ten females and can be diagnosed in adolescence. As adolescents with PCOS transition to adulthood, counselling for lifestyle management and mental health concerns often transition from involving the family unit to increasingly individual-focused approaches. PCOS is associated with a large range of comorbidities affecting reproductive, metabolic, dermatological, and psychological health. The diagnosis and comorbidities of PCOS are influenced by pubertal hormones and need to be reassessed continuously to ensure that treatment remains appropriate for age and development. As young patients grow up, personal concerns often change, especially in relation to reproductive management. In this Review, we present prevalence rates, screening tools, and treatment recommendations for PCOS-related conditions, and we consider the diagnostic and clinical elements of optimal transition of care models that ensure continuity of comprehensive care for adolescents moving from the paediatric health-care system to the adult health-care system.

Citing Articles

What can we do for the adolescents with polycystic ovary syndrome?.

Chen Y, Tang Y, Li X, Wang X World J Pediatr. 2024; 20(12):1205-1208.

PMID: 39614993 DOI: 10.1007/s12519-024-00857-4.


Optimising healthcare transition of adolescents and young adults to adult care: a perspective statement of the Italian Society of Obesity.

Morandi A, Umano G, Vania A, Gugliemi V, Muscogiuri G, Maffeis C Eat Weight Disord. 2024; 29(1):51.

PMID: 39097845 PMC: 11298504. DOI: 10.1007/s40519-024-01678-0.

References
1.
Spitzer R, Kroenke K, Williams J, Lowe B . A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006; 166(10):1092-7. DOI: 10.1001/archinte.166.10.1092. View

2.
Weghuber D, Barrett T, Barrientos-Perez M, Gies I, Hesse D, Jeppesen O . Once-Weekly Semaglutide in Adolescents with Obesity. N Engl J Med. 2022; 387(24):2245-2257. PMC: 9997064. DOI: 10.1056/NEJMoa2208601. View

3.
Wild R . Long-term health consequences of PCOS. Hum Reprod Update. 2002; 8(3):231-41. DOI: 10.1093/humupd/8.3.231. View

4.
Benson J, Severn C, Hudnut-Beumler J, Simon S, Abramson N, Shomaker L . Depression in Girls With Obesity and Polycystic Ovary Syndrome and/or Type 2 Diabetes. Can J Diabetes. 2020; 44(6):507-513. PMC: 7428465. DOI: 10.1016/j.jcjd.2020.05.015. View

5.
Flynn K, Lindau S, Lin L, Reese J, Jeffery D, Carter J . Development and Validation of a Single-Item Screener for Self-Reporting Sexual Problems in U.S. Adults. J Gen Intern Med. 2015; 30(10):1468-75. PMC: 4579234. DOI: 10.1007/s11606-015-3333-3. View